0B68 Gomella, Leonard - Thomas Jefferson University - Thomas Jefferson University

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
  2. Decipher correlation patterns post prostatectomy: initial experience from 2‚ÄČ342 prospective patients
  3. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  4. Editorial Commentary
  5. VPAC1 targeted 64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man
  6. Big data equals big challenges for prostate cancer
  7. TV drug commercials: Keeping physicians informed
  8. How I Do It: Genetic counseling and genetic testing for inherited prostate cancer
  9. Dosing, administration, and safety of radium-223: How i do it
  10. Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin
  11. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer
  12. Radical Retropubic Prostatectomy
  13. Survival outcomes of sipuleucel-T phase III studies: Impact of control-arm cross-over to salvage immunotherapy
  14. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  15. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience
  16. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  17. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
  18. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  19. Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation therapy oncology group randomized clinical trial 9910
  20. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer